Dynavax Technologies Aktie

13,54 +0,52% +0,07 €
09:15 Uhr Frankfurt | Orderbuch | Mehr Kurse »
WKN: A12EV9
ISIN: US2681582019
US-Symbol: DVAX
Typ: Aktie

Performance Dynavax Technologies Aktie

  
1 Woche 1 Monat 3 Monate Lfd. Jahr 1 Jahr 3 Jahre
Kurs 15,90 $ 16,60 $ 18,40 $ 18,70 $ 9,35 $ 22,00 $
Änderung +0,31% -3,92% -13,32% -14,71% +70,59% -27,50%

Forum zur Dynavax Technologies Aktie

  
Kurios1: GlaxoSmithKline
10.11.17
The vaccine is an important product for Dynavax, given its potential. At present, the standard-​of-care for the hepatitis B virus is GlaxoSmithKline plc (ADR) (NYSE: GSK)'s Energix-B. This vaccine fetched GlaxoSmithKline sales of 210 million pounds or roughly $275 million for ...
iwanooze: dynavax news
28.11.14
http://www.wallstreet-​online.de/nachricht/7208949-dynavax-​regains-full-rights-to-investigational-tlr-7-9-inhibitor-dv1179-following-​expiration-of-collaboration-with-gsk

Analysen

  
Kaufen Halten Verkaufen
Analysten 0 0 0
Markt-Lotsen 0 0 0

Dynavax Technologies Aktie & Unternehmen

  
Branche Biotechnologie
Herkunft USA
Website www.dynavax.com
Aktienanzahl 60,6 Mio. (Stand: 24.01.18)
Marktkap. 820,5 Mio. €

Dividenden & Splits

  
11.11.14 Reverse Split 10:1 Frankfurt, Stuttgart, Berlin
10.11.14 Reverse Split 10:1 Nasdaq

Ähnliche Aktien

  
Name
last
change_rel
 
Heat Biologics 2,10 € -2,33%
Trevena 1,48 € +2,07%
Celgene 69,01 € +0,10%
Evofem Biosciences 2,99 € +9,12%
CV Sciences 1,45 € -13,17%